Veradermics to Present at the Jefferies Global Healthcare Conference in London
Business Wire•12/11/2026•16:30 ET
0
Key Highlights
- ➤Veradermics to present at Jefferies Global Healthcare Conference November 19, 2026
- ➤VDPHL01 is in Phase 3 development for pattern hair loss
- ➤VDPHL01 is an investigational extended-release oral minoxidil tablet
- ➤VDPHL01 patent protection extends earliest expiration to 2043
Veradermics to Present at the Jefferies Global Healthcare Conference in London
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that company management will present at the Jefferies Global Healthcare Conference in London on Thursday, November 19, 2026, at 8:30 a.m. GMT / 3:30 a.m. EST.
Get started
Create a free account to read the full story.